Smoking Cessation: Recent Developments in Behavioral and Pharmacologic Interventions

ONCOLOGY

Volumn 12, Issue 2, 1998, Pages 249-259

  Cinciripini, Paul M ^a   McClure, Jennifer B ^b  

^a Department of Behavioral Science ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CLONIDINE; DEXFENFLURAMINE; FLUOXETINE; MOCLOBEMIDE; NICOTINE DERIVATIVE; NICOTINIC RECEPTOR BLOCKING AGENT; NORTRIPTYLINE; VENLAFAXINE;

BEHAVIOR THERAPY; CANCER RISK; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PATIENT COUNSELING; REVIEW; RISK MANAGEMENT; SMOKING; SMOKING CESSATION;

BEHAVIOR; HUMANS; SMOKING CESSATION;

EID: 0031932034     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. USDHHS: The Health Benefits of Smoking Cessation: A Report of the Surgeon General. DHHS pub. no (CDC) 90-8416. Washington, DC, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health, 1990.
2. CDC: Cigarette smoking-attributable mortality and years of potential life lost: United States, 1990. Morbid Mortal Weekly Rep 42:854-857, 1993.
3. USDHHS: Cancer: Rates and Risks, 4th ed. NIH (NCI) publication no. 96-691. Washington, DC, US Department of Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1996.
4. Newcombe PA, Carbone PP: The health consequences of smoking. Cancer. Med Clin North Am 76:305-331, 1992.
5. Samet JM: The health benefits of smoking cessation. Med Clin North Am 76:399-414, 1992.
6. CDC: Cigarette smoking among adults - United States, 1994. Morbid Mortal Weekly Rep 45:588-590, 1996.
7. CDC: Smoking cessation during previous year among adults - United States 1990 & 1991. Morbid Mortal Weekly Rep 42:504-507, 1993.
8. Fiore MC, Novotony TE, Pierce JP, et al: Methods used to quit smoking in the United States. JAMA 263:2760-2765, 1990.
9. Cohen S, Lichtenstein E, Prochaska JO. Debunking myths about self-quilting. Evidence from ten prospective studies of persons quitting smoking by themselves. Am Psychol 44:1955-1965, 1989.
10. Fiore MC, Bailey WC, Cohen SJ, et al: Smoking Cessation. Clinical Practice Guideline no. 18, AHCPR publication no. 96-0692. Rockville, Maryland, US Department of Health and Human Service. Agency for Health Care Policy and Research, April 1996.
11. Prochaska JO, DiClemente CC, Velicer WF, et al: Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 12:399-405, 1993.
12. Schneider SJ, Schwartz MD, Fast J: Computerized, telephone-based health promotion: I. Smoking cessation program Comput Hum Behav 1:135-148, 1995.
13. Strecher VJ, Kreuter M, Den Boer D-J, et al: The effects of computer-tailored smoking cessation messages in family practice settings J Fam Pract 39:262-270, 1994.
14. Cinciripini PM, Lapitsky L, Scay S, et al: The effects of smoking schedules on cessation outcome' Can we improve on common methods of gradual and abrupt nicotine withdrawal? J Consult Clin Psychol 63:388-399, 1995.
15. Cinciripini PM. Current trends in smoking cessation research: Psychological therapy, nicotine replacement, and changes in smoking behavior. Cancer Bull 47:259-263, 1995.
16. Hughes JR: Combining behavioral therapy and pharmacotherapy for smoking cessation: An update, in Onken LS, Blaine JD, Boren JJ, (eds). Integrating NIDA Research. Monograph 92-109. Washington, DC, US Government Printing Office, 1995.
17. Cepeda-Benito A: A meta-analytic review of the efficacy of nicotine chewing gum in smoking cessation treatment programs. J Consult Clin Psychol 61:822-30, 1993.
18. Silagy C, Mant D, Fowler G, et al: Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343:139-142, 1994.
19. Tang JI, Law M, Wald N: How effective is nicotine replacement therapy in helping people to stop smoking? Br Med J 308:21-26, 1994.
20. Fiore MC, Smith SS, Jorenby DE, et al: The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. JAMA 271:1940-1947, 1994.
21. Gourlay S: The pros and cons of transdermal nicotine therapy. Med J Aust 160:152-159, 1994.
22. Po ALW: Transdermal nicotine in smoking cessation: A meta-analysis. Eur J Clin Pharmacol 45:519-28, 1993.
23. Pierce JP, Gilpin E, Farkas AI: Nicotine patch use in the general population: Results from the 1993 California tobacco survey. J Natl Cancer Inst 87:87-93, 1995.
24. Willey C, Laforge R, Prochaska J, et al: Transdermal nicotine usage in a randomly selected population based sample of smokers. Ann Behav Med 17:S069, 1995.
25. Orleans CT, Resch N, Noll E, et al: Use of transdermal nicotine in a state-level prescription plan for the elderly. JAMA 271:601-607, 1994.
26. Kornitzer M, Boutsen M, Draxaix M, et al: Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial. Prev Med 24:4147, 1995.
27. Puska P, Korhonen J, Vartialnen E, et al: Combined use of the nicotine patch and gum compared with gum aline in smoking cessation: A clinical trial in North Karelia. Tob Control 4:231-235, 1995.
28. Schneider NG, Lunell E, Olmstead RE, et al: Clinical pharmacokinetics of nasal nicotine delivery - A review and comparison of other nicotine systems. Clin Pharmacokinet 31:65-80, 1996.
29. Schneider NG, Olmstead R, Mody FV, et al: Efficacy of a nicotine nasal spray in smoking cessation - A placebo-controlled double-blind trial. Addiction 90:1671-1682, 1995.
30. Tonnesen P, Mikkelsen K, Norregaard J, et al: Recycling of hard-core smokers with nicotine nasal spray. Eur Respir J 9:1619-1623, 1996.
31. Schneider NG, Olmstead R, Freny Vaghaiwalla M, et al: Nicotine inhaler in smoking cessation: A double-blind, placebo-controlled trial. Presented at the Second Annual Conference for the Society for Research on Nicotine and Tobacco, Washington, DC, 1996.
32. Hughes JR: Non-nicotine pharmacotherapies for smoking cessation. J Drug Dev 6:197-203, 1994.
33. Clarke PBS: Nicotinic receptor blockade therapy and smoking cessation. Br J Addict 86:501-555, 1991.
34. Collins AC, Evans CB, Miner LL, et al: Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors. Pharmacol Biochem Behav 24:1767-1773, 1986.
35. Stolerman IP: Could nicotine antagonists be used in smoking cessation? Br J Addict 81:47-53, 1986.
36. Rose JE, Sampson A, Levin ED, et al: Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32:933-938, 1989.
37. Nemeth-Coslett R, Henningfield JE, O'Keeffe MK, et al: Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology (Berl) 88:420-425, 1986.
38. Stolerman P, Goldfarb T, Fink R, et al: Influencing cigarette smoking with nicotine antagonists. Psychopharmacology (Berl) 28:27-59, 1973.
39. Rose JE, Behm FM, Westman EC, et al: Mecamylarnine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Trials Ther 56: 86-99, 1994.
40. Gourlay SG, Benowitz NL: Is clonidine effective smoking cessation therapy? Drugs 50:197-207, 1995.
41. Niaura R, Brown RA, Goldstein MG, et al: Transdermal clonidine for smoking cessation: A double-blind randomized dose-response study Exp Clin Psychopharmacol 4:285-291, 1996.
42. Jann MW: Buspirone An update on a unique anxiolytic agent. Pharmacotherapy 8:100-116, 1988.
43. Taylor DP, Moon SL: Buspirone and related compounds as alternative anxiolytics. Neuropeptides 19:15-9, 1991.
44. Eison AS, Temple DL: Buspirone: A review of its pharmacology, current perspectives on its mechanism of action. Am J Med 80:1-9, 1986.
45. Robinson MD, Smith WA, Cederstrom EA, et al: Buspirone effect on tobacco withdrawal symptoms: A pilot study. J Am Board Fam Pract 4:89-94, 1991.
46. Robinson MD, Pettice YL, Smith WA: Buspirone effect on tobacco withdrawal symptoms: A randomized placebo-controlled trial. J Am Board Fam Pract 5:1-9, 1992.
47. West R, Hajek P, McNeill A: Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology(Berl) 104:91-96, 1991.
48. Hilleman DE, Mohiuddin SM, Delcore MG, et al. Effect of buspirone on withdrawal symptoms associated with smoking cessation. Arch Intern Med 152:350-352, 1992.
49. Cinciripini PM, Lapitsky L, Seay S, et al: A placebo-controlled evaluation of the effects of buspirone on smoking cessation: Differences between high- and low-anxiety smokers. J Clin Psychopharmacol 15:182-191, 1995.
50. Schneider NG, Olmstead RE, Steinberg C, et al: Efficacy of buspirone in smoking cessation: A placebo-controlled trial. Clin Pharmacol Ther 60:568-575, 1996.
51. Fowler JS, Volkow ND, Wang GJ, et al: Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93:14065-14069, 1996.
52. Berlin I, Said S, Spreux-Varoquaux O, et al: A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Trial Ther 58:444-452, 1995.
53. Niaura R, Goldstein M, Spring B, et al: Fluoxetine for smoking cessation: A multicenter randomized double blind dose response study. Ann Behav Med 19:3042, 1997.
54. Spring B, Wurtman J, el-Khoury A, et al: Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation. Am J Clin Nutr 62:1181-1187, 1995.
55. Doherty K, Militello FS, Kinnunen T, et al: Nicotine gum dose and weight gain after smoking cessation. J Consult Clin Psychol 64:799-807, 1996.
56. Nides M, Rand C, Dolce J, et al: Weight gain as a function of smoking cessation and 2-mg nicotine gum use among middle-aged smokers with mild lung impairment in the first 2 years of the lung health study. Health Psychol 13:354-361, 1994.
57. Hurt RD, Sachs DPL, Glover ED, et al: A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195-1203, 1997.
58. Hall SM: New directions in medications for the treatment of tobacco dependence. Presented at the Society for Reasearch on Nicotine and Tobacco, Washington, DC, 1996.
59. Cinciripini P, Tsoh J, Friedman K, et al: A placebo controlled evaluation of venlafaxine for smoking cessation Preliminary findings. Soc Res Nic Tob, 1997